1)Varadhachary GR, Raber MN:Cancer of unknown primary site. N Engl J Med 371:757-765, 2014
2)Fizazi K, et al:Cancers of unknown primary site;ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol Off J Eur Soc Med Oncol 26 Suppl 5:v133-138, 2015
3)近藤 猛,他:第10回JHNセミナー:内科医として知っておきたい がん患者を診る上での必須知識;原発不明がん配付資料.2019.
4)Vikeså J, et al:Cancers of unknown primary origin(CUP)are characterized by chromosomal instability(CIN)compared to metastasis of know origin. BMC Cancer 15:151, 2015
5)Ettinger DS, et al:NCCN clinical practie guidelines in oncology-Occult primary. 59, 2019 http://www.nccn.org/professionals/physician-g/s/default.aspx#occult(2019年6月閲覧)
6)Chen KW, et al:Evaluation of prognostic factors and the role of chemotherapy in unfavorable carcinoma of unknown primary site;A 10-year cohort study. BMC Res Notes 5:70, 2012
F-FDG PET/CT as a diagnostic tool in patients with extracervical carcinoma of unknown primary site;A literature review. Oncologist 16:445-451, 2011